Detalhe da pesquisa
1.
Tmem30a Plays Critical Roles in Ensuring the Survival of Hematopoietic Cells and Leukemia Cells in Mice.
Am J Pathol
; 188(6): 1457-1468, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29574182
2.
SKLB060 Reversibly Binds to Colchicine Site of Tubulin and Possesses Efficacy in Multidrug-Resistant Cell Lines.
Cell Physiol Biochem
; 47(2): 489-504, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29794416
3.
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.
J Chem Inf Model
; 57(4): 669-679, 2017 04 24.
Artigo
Inglês
| MEDLINE | ID: mdl-28301150
4.
Survival regulation of leukemia stem cells.
Cell Mol Life Sci
; 73(5): 1039-50, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26686687
5.
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.
Blood
; 123(5): 706-16, 2014 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-24319254
6.
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells.
Blood
; 120(19): 3958-67, 2012 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-22983447
7.
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.
Blood
; 120(9): 1877-87, 2012 Aug 30.
Artigo
Inglês
| MEDLINE | ID: mdl-22689860
8.
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.
Blood
; 119(24): 5772-81, 2012 Jun 14.
Artigo
Inglês
| MEDLINE | ID: mdl-22538852
9.
Therapeutic potential of a synthetic dual JAK1/TYK2 inhibitor in inflammatory bowel disease.
Int Immunopharmacol
; 126: 111238, 2024 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37988912
10.
Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer.
Adv Sci (Weinh)
; 11(13): e2306364, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38286670
11.
A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia.
Blood
; 118(2): 390-400, 2011 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-21596859
12.
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.
Nat Genet
; 36(5): 453-61, 2004 May.
Artigo
Inglês
| MEDLINE | ID: mdl-15098032
13.
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model.
J Vis Exp
; (193)2023 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37010279
14.
Sub-micron microparticles with tunable fluorescence emission obtained via co-self-assembly of amidoximed polymeric ligands and lanthanide ions.
Front Chem
; 11: 1209264, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37265591
15.
Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function.
Cell Oncol (Dordr)
; 46(4): 1069-1083, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36930333
16.
Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma.
J Exp Clin Cancer Res
; 42(1): 311, 2023 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37993901
17.
TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN.
Signal Transduct Target Ther
; 8(1): 90, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36854750
18.
HDAC I/IIb selective inhibitor Purinostat Mesylate combined with GLS1 inhibition effectively eliminates CML stem cells.
Bioact Mater
; 21: 483-498, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36185739
19.
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias.
Nat Cancer
; 4(5): 754-773, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37237081
20.
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.
Blood
; 116(17): 3227-37, 2010 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-20651070